Tue, May 13, 8:31 PM (9 days ago)
Xenetic Biosciences, Inc. (XBIO) filed an amendment to its 2024 Annual Report on Form 10-K/A. The amendment includes updates to executive compensation details and certifications. Key points: **Financial Performance:** - **Revenue and Net Income:** Not explicitly stated in the provided text. - **Operating Expenses:** Not explicitly stated in the provided text. - **Earnings Per Share (EPS):** Not explicitly stated in the provided text. **Strategic Overview:** - The company has made changes to executive compensation structures, including severance packages and stock option grants. - The amendment includes updated certifications from the Principal Executive Officer and Principal Financial Officer. **Future Outlook:** - The company's strategic, financial, and operating performance objectives are tied to total shareholder return (TSR) and net loss improvements. - The compensation committee's decisions are aligned with these performance objectives. **Risk Factors:** - The amendment does not explicitly discuss risk factors but implies potential risks related to executive turnover and compensation structures. **Financial Condition:** - The company's financial condition is not explicitly detailed in the provided text. **Market Position Changes:** - The company's market position changes are not explicitly detailed in the provided text. **Executive Compensation:** - **James Parslow (Interim CEO & CFO):** Received a total compensation of $481,168 in 2024, including a salary of $378,378, option awards of $67,280, and other compensation of $35,510. - **Jeffrey Eisenberg (Former CEO):** Received a total compensation of $673,143 in 2024, including severance payments. - **Dr. Curtis Lockshin (Former CSO):** Received a total compensation of $554,083 in 2024, including severance payments. **Director Compensation:** - Non-employee directors received an annual retainer of $43,000 and stock option awards. **Changes Made in the Amendment:** - The amendment adds a new paragraph under "Equity Award Grant Practices" in Item 11 of Part III. - Includes updated certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. - No financial statements are included, and the amendment does not update any other information in the original filing.